Monday, July 12, 2010

FDA to Consider Qnexa this week

Obesity is a major health issue in the United States, with almost 35% of Americans being classified as obese.  A new weight loss drug Qnexa shows promise as being both safe and effective in aiding weight loss when combined with diet and exercise.  Patients in the Qnexa clinical trials lost between 13 and 15% of their body weight, while experiencing mild side effects.  The FDA Advisry board meets to review Qnexa on Thursday, July 15, with a targetted approval date in October.

Posted via email from susan's posterous

No comments:

Post a Comment